and collaboratively kill target cells. 7 A recent study found that programmed-death-1 (PD-1), an inhibitory checkpoint molecule, is expressed on NK cells. Given this, the regulation of PD-1 expression on NK cells might provide therapeutic potential for antitumor immunotherapy. 3 Histidine-rich glycoprotein (HRG) is a 75-kDa glycoprotein produced by the liver. Plasma levels of HRG are maintained at approximately 1 μmol/L, with a relatively rapid turnover. 8, 9 Because of its multidomain, three-dimensional structure, HRG binds a variety of molecules such as heparin, fibrinogen, and heme, 9 which facilitate numerous modulatory activities, such as cell adhesion, angiogenesis, and thrombosis. [10] [11] [12] Researchers have hypothesized that decreased plasma levels of HRG are responsible for the development of pulmonary fibrosis, preeclampsia, and sepsis. 13, 14 In septic pathophysiology, the rapid decrease in plasma HRG might diminish its regulatory effects on neutrophils, vascular endothelial cells, and erythrocytes, leading to impaired passage of neutrophils through capillary vessels.
It may also cause injury to vascular endothelial cells via the production of reactive oxygen species by adhered neutrophils and the formation of immune-thrombosis. [13] [14] [15] [16] [17] [18] [19] Thus, physiological concentrations of HRG in plasma might maintain the quiescence of circulating neutrophils preventing the uncontrolled activation of vascular endothelial cells and thrombus formation. 18 Moreover, plasma HRG is markedly decreased in septic patients in intensive care units, and it is superior to procalcitonin and presepsin as a biomarker in predicting sepsis. 14 In addition, HRG might potentiate the antitumor effects of tumor-associated macrophages via antiangiogenic effects. 20, 21 Some researchers suggest that NK cell-mediated cytotoxicity is augmented by various therapeutic agents and peptides. 22 40 More recently, it was suggested that CLEC-1B expression levels can predict outcome for certain cancers. 37 These reports make CLEC-1B a fascinating therapeutic target when considering antitumor immunity.
Here, we hypothesized that the inhibitory effects of HRG on tumors could be attributed to its direct immunomodulatory effects on NK cells through the augmentation of cytokine production and modulation of PD-1 expression. We also anticipated that CLEC, especially CLEC-1B, might be a potential receptor for HRG. The purpose of this study was to examine whether HRG enhances NK cell cytotoxicity and regulates cytokine production by these cells through the stimulation of specific receptors, focusing on revealing molecular and pathological associations with antitumor immunity. 
| MATERIAL S AND ME THODS

| Antibodies and reagents
| HRG purification from human plasma
HRG was purified from fresh frozen plasma samples obtained from the Japanese Red Cross Society as previously described. Gladbach, Germany).
| Cytometric bead analysis (CBA)
Concentrations
| Cell surface PD-1 expression analysis
To elucidate the effects of HRG on PD-1 expression on NK cells, these cells were cultured overnight with 5% CO 2 at 37°C after purifi- antibodies for flow cytometric analysis using a MACSQuant Analyzer.
| Effects of anti-CLEC antibodies on the effect of HRG immunomodulation
Anti-CLEC-1A, anti-CLEC-1B polyclonal, and goat IgG control antibodies were added to each group subjected to PD-1 analysis. The analysis of NK cell surface PD-1 expression was performed as described for each method. For this, 0.5 μmol/L HRG or 0.5 μmol/L HSA were added to each group. Anti-CLEC and control antibodies were added at a concentration of 10 μg/mL before coculture.
| Observation of NK cell morphological changes
To clarify the effects of HRG on NK cell morphology, the cells were incubated with HRG, HSA, or HBSS at 1 μmol/L for 4 hours after overnight stimulation with IL-2-containing RPMI1640. Cell shape was observed by calcein staining as described previously. 18 An IN Cell Analyzer 2000 System (GE Healthcare, Little Chalfont, UK)
was used for observation. The data were analyzed using IN Cell
Investigator Version 1.62 (GE Healthcare, Little Chalfont, UK).
| Observation of F-actin/G-actin distribution in NK cells
After overnight incubation with IL-2, NK cells were cocultured with K562 at a 10:1 E:T ratio in the presence of HRG, HSA, or HBSS at 1 μmol/L for 4 hours in RPMI1640. The cell suspensions were then gelatinized using Smear Gell (GenoStaff, Tokyo, Japan) on aminopropyltriethoxy silane (APS)-coated glass slides (Matsunami, Tokyo, Japan) according to the manufacturers' instructions. Cells were then fixed with 4% paraformaldehyde. After fixation, the cells were treated with 0.1% triton-X-100 for membrane permeabilization, followed by staining with Phalloidin-Alexa568 (F-actin), DNase IAlexa488 (G-actin), and DAPI (nuclei). Samples were observed with a confocal microscope (LSM780, Carl Zeiss, Oberkochen, Germany).
| Statistical analysis
Tukey-Kramer or one-way ANOVA tests were performed. Data are presented as mean values ± SEM. P-values <0.05 were considered statistically significant. All statistical analyses were conducted using JMP Version 13 (SAS Institute, Cary, NC).
| RE SULTS
| HRG augments NK cell-mediated cytotoxicity toward K562 cells
Cytotoxicity peaked with an 80:1 E:T ratio ( Figure 1A ). After confirming the appropriate E:T ratio, NK cell cytotoxicity was assessed quantitatively by measuring LDH release in the supernatants of NK and K562 cell cocultures. To examine whether NK cell cytotoxicity was augmented in the presence of HRG, we first compared the cytotoxicity of PBMCs against K562 cells.
Based on these results, 1 μmol/L HRG significantly increased NK cell-mediated cytotoxicity compared to HBSS and HSA groups ( Figure 1A ). Next, we cocultured purified NK cells with K562 cells to rule out the possibility that HRG was effecting PBMCs other than NK cells. We observed a similar dose-dependent increase in cytotoxicity; a significant effect was noted with a concentration of 1 μmol/L. Incubation with HBSS and HSA did not produce any effects ( Figure 1B ).
| Effects of HRG on cytokine production and granzyme B secretion from NK cells
To explore the mechanism through which HRG modulates NK cell Figure 3A-C) . The effects of HRG on promoting differentiation into CD56 bright cells were also significant in groups not pretreated with IL-2 ( Figure 3B) . Consistent with the increase in the CD56 bright cell population, the percentage of CD56 dim cells decreased in the HRGtreated group ( Figure 3C ).
| HRG increases
| PD-1 expression is decreased by HRG treatment
Because 
| An anti-CLEC-1B polyclonal antibody inhibits the effects of HRG on NK cell PD-1 expression
Next, we hypothesized that CLEC-1B, a C-type lectin-like receptor that is expressed on NK cells, could be a HRG receptor on NK cells based on previous reports suggesting a relationship between CLEC-1B and tumor immunity. 35 Due to an abundance of potential epitopes, we used human anti-CLEC polyclonal antibodies to examine the effect of HRG on NK cell PD-1 expression. Anti-CLEC antibodies were used at 10 μg/mL to minimize the immunomodulatory effects of the antibodies themselves. We set out to determine if the anti-CLEC-1B antibody could inhibit the effects of HRG on PD-1 expression by flow cytometric analysis. As shown in Figure 5A ,B, the anti-CLEC-1B antibody significantly inhibited this effect by suppressing cell surface PD-1 expression, whereas the effect of anti-CLEC-1A
was not significant.
| HRG induces morphological changes associated with compact nuclear shapes and actin distribution in NK cells
Finally, based on a previous report that HRG induces morphological changes in neutrophils, to a more spherical shape, which were found to be associated with functional alterations, 18 we speculated that similar effects could occur with NK cells. In addition, because the nuclear shape is associated with mechanical forces exerted by the cytoskeleton and because NK cell lytic granules are transported along F-actin fibers, 44 we utilized a live cell imaging device and confocal microscopy to visualize morphological changes. In HRG groups, NK cell nuclei became significantly rounder compared to those in HBSS and HSA groups ( Figure 6A -C). Based on fluorescent confocal microscopy analysis, we determined that F-actin staining was localized mainly to the plasma membrane in a circular pattern in the HRG group. In contrast, F-actin was observed as spots in HBSS and HSA groups ( Figure 6D -E). Infiltration by these cells was negatively correlated with tumor stage, which suggested that CD56 bright NK cells might be important for antitumor surveillance. 45 Interestingly, our results suggest that HRG both increases direct cytotoxic activity and the proportion of CD56 bright NK cells. Therefore, it may be possible Recently, CLEC-1B expression has received attention for its prognostic value in some types of malignancies; specifically, low CLEC-1B expression indicates poor prognosis. 37 Moreover, a previous report suggested that CLEC-1B might suppress tumor aggressiveness via the phosphoinositide 3-kinase/AKT pathway. 40 Based on the previous finding that low CLEC-1B and high PD-L1 expression both indicate poor prognosis for malignancies, it is plausible that HRG, which functions via CLEC-1B to suppress NK cell surface PD-1 expression has an important role in oncologic immunotherapy.
| D ISCUSS I ON
We also revealed that HRG modulates the nuclear shapes of NK cells, such that they become rounder. Additionally, we discovered that HRG modulates F-actin distribution by inducing its precise arrangement circumferentially below the cytoplasmic membrane. This change in F-actin distribution was previously observed in neutrophils, 18 suggesting that HRG might exert its function on different myeloid cells in a similar fashion. Cell nuclear shapes are partially controlled by cytoskeletal tension, mainly induced by actin. 49 Rounder cell nuclei reportedly correspond to increased gene expression, which might reflect increased cell activity. 49 F-actin remodeling is important for the regulation of cytotoxic granule secretion. 32, 44 Notably, our data provide evidence that HRG also influences actin remodeling, which could establish streamlined cytotoxicity via lytic granule secretion, as well as cytokine production and possibly elevated gene expression.
Overall, our results illuminate the diverse and significant effects of HRG on NK cell cytotoxicity, which was found to occur through various pathways, via CLEC-1B. 
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